Source: Antimicrobial Agents and Chemotherapy. Unidade: IF
Assunto: ESQUISTOSSOMOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA, Rafael A et al. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, v. 63, n. 3, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.1128/AAC.01722-18. Acesso em: 03 nov. 2024.APA
Guerra, R. A., Silva, M. P., Silva, T. C., Salvadori, M. C. B. da S., Teixeira, F. S., Oliveira, R. N. de, et al. (2019). In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, 63( 3), 1-11. doi:10.1128/AAC.01722-18NLM
Guerra RA, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1128/AAC.01722-18Vancouver
Guerra RA, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1128/AAC.01722-18
